Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada.

导出 LinkOut

翻译打印收藏纠错

作者： Philip A,McFarlane ^[1] ; Mina,Madan ^[2] ; Anne M,Ryschon ^[3] ; Sheldon,Tobe ^[4] ; Ernesto L,Schiffrin ^[5] ; Raj S,Padwal ^[6] ; Ross,Feldman ^[7] ; George,Dresser ^[8] ; Lindsay,Machan ^[9] ; Hamid,Sadri ^[10] ; Khoa N,Cao ^[3] ; Jan B,Pietzsch ^[3]

作者单位： Division of Nephrology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. ^[1] Schulich Heart Program, Sunnybrooke Health Sciences Centre, Toronto, Ontario, Canada.;Division of Cardiology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. ^[2] Wing Tech Inc., Menlo Park, California, USA. ^[3] University of Toronto, Toronto, Ontario, Canada.;Northern Ontario School of Medicine, Adult Nephrology, University of Toronto, Toronto, Ontario, Canada. ^[4] Department of Medicine, McGill University, Montreal, Quebec, Canada.;Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.;Cardiovascular Prevention Centre, Montreal, Quebec, Canada.;Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada. ^[5] University of Alberta, Edmonton, Alberta, Canada. ^[6] University of Western Ontario, London, Ontario, Canada. ^[7] Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. ^[8] Division of Vascular Surgery, Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada. ^[9] Department of Health Economics Outcomes Research, Medtronic, Toronto, Ontario, Canada. ^[10]

关键词 C50 Canada D61 Hypertension I10 cost-effectiveness analysis radiofrequency ablation renal denervation